INS and polycystic ovary syndrome: Nonetheless, we found that the clinical performance of this screening algorithm remained satisfactory in the pooled validation cohort with reasonable sensitivity and high NPV of over 90%, indicating that this algorithm should be also applicable to individuals who are relatively insulin resistant either due to PCOS or more severe obesity.